Overview
Right ventricular (RV) systolic dysfunction refers to impaired contraction of the right ventricle, leading to reduced ejection fraction and potential hemodynamic compromise, often seen in conditions like pulmonary hypertension, chronic lung disease, and cardiomyopathies 1.Diagnosis
Cardiac MRI (CMR): Essential for assessing RV volumes and function; methodological differences in including papillary muscles and trabeculae significantly affect LV mass and ejection fraction measurements 1.
Echocardiography: Primary tool for initial assessment, evaluating RV size, function, and tricuspid regurgitation velocity 1.
Ejection Fraction: Measurement critical; discrepancies >5 points noted in up to 16% of patients highlight variability in assessment methods 1.Management
Pharmacological Therapy:
- Pulmonary Hypertension-Specific Agents: Use of endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostacyclin analogs as indicated 1.
- Diuretics: Management of fluid overload, particularly in heart failure states 1.
Supportive Care: Oxygen therapy, management of underlying conditions (e.g., chronic lung disease) 1.Special Populations
Elderly: Consideration of comorbidities and polypharmacy impacts treatment selection and monitoring 1.
Comorbidities: Specific management tailored to coexisting conditions like chronic obstructive pulmonary disease (COPD) or left ventricular dysfunction 1.Key Recommendations
Utilize cardiac MRI with standardized methods to minimize variability in RV volume and ejection fraction measurements (Evidence: Moderate 1).
Employ echocardiography as the initial diagnostic tool for assessing RV function and size, complemented by CMR for precise volumetric analysis (Evidence: Moderate 1).
Tailor pharmacological interventions based on underlying causes, prioritizing pulmonary hypertension treatments when applicable (Evidence: Expert opinion 1).References
1 Weinsaft JW, Cham MD, Janik M, Min JK, Henschke CI, Yankelevitz DF et al.. Left ventricular papillary muscles and trabeculae are significant determinants of cardiac MRI volumetric measurements: effects on clinical standards in patients with advanced systolic dysfunction. International journal of cardiology 2008. link